Quillivant XR 25 MG/5 ML susp 60ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F6H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,266
Award facts
- Contract value 100% obligated
- $10,266.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,266.37 delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Quillivant XR 25 mg/5 mL suspension in 60 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Quillivant XR is an extended-release formulation of methylphenidate used in the treatment of attention-deficit/hyperactivity disorder and represents one of many pharmaceutical products distributed through the contractor's federal supply network.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime indefinite delivery vehicle enables comprehensive global pharmaceutical support to military healthcare programs, covering specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical vendor for military and veteran healthcare systems, competing successfully on a full and open basis for pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F4F6H?
SPE2DR26F4F6H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F4F6H worth?
The government has obligated $10,266 on SPE2DR26F4F6H.
Is contract SPE2DR26F4F6H an order under another contract?
Yes. SPE2DR26F4F6H is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F6H competed?
The extent of competition for SPE2DR26F4F6H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award